Overview

Study to Evaluate the Efficacy of Octenisept® in Patients With Chronic Wounds

Status:
Terminated
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled trial with octenisept® or placebo in patients with chronic leg ulcers. The study will be conducted at a single center with a total of 70 patients. Patients will be randomized to either the octenisept® group or to the placebo group.
Phase:
Phase 4
Details
Lead Sponsor:
Schülke & Mayr GmbH
Treatments:
Octenidine